Clinical trial · Observational
Perception of the COVID-19 Pandemic in Patients With Haematological or Solid Neoplasias
Investigation of the Perception of the COVID-19 Pandemic in Patients With Haematological or Solid Neoplasias Using Patient-reported Outcome Measures (PROMs)
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Cancer patients are among the most vulnerable individuals, whose health-related quality of life (HRQOL) may be substantially impacted by the COVID19 pandemic. We want to study how the COVID-19 pandemic influences the life of cancer patients and how these patients cope with the additional distress with the aim to facilitate the development of improved future interventional strategies to maintain resilience and HRQOL
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Covid19 | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| questionnaire | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- cancer patients
- description
- adult cancer patients, with solid or hematologic malignancies, neither tested positive nor having COVID19 symptoms
- interventionNames
- Other: questionnaire
Primary outcomes (1)
- measure
- Influence of the COVID-19 pandemic on cancer patient's daily life
- timeFrame
- single time
- description
- evaluation via questionnaire
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age \> 18 years * validated hematological or oncological disease * informed consent Exclusion Criteria: * Age \< 18 years * Insufficient discernment
References
Publications (0)
Data not yet available